Multicenter randomized trial of 3-month cilostazol use in addition to dual antiplatelet therapy after biolimus-eluting stent implantation for long or multivessel coronary artery disease

American Heart Journal

Volumn 167, Issue 2, 2014, Pages

  Youn, Young Jin ^a   Lee, Jun Won ^a   Ahn, Sung Gyun ^a   Lee, Seung Hwan ^a   Choi, Hyunmin ^b   Yu, Cheol Woong ^c   Hong, Young Joon ^d   Kwon, Hyuck Moon ^e   Hong, Myeong Ki ^f   Jang, Yangsoo ^f   Yoon, Junghan ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Inje University   (South Korea)

^c Sejong General Hospital   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; UMIROLIMUS;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; DRUG ERUPTION; DRUG SAFETY; DRUG THERAPY; DRUG USE; DRUG WITHDRAWAL; DUAL ANTIPLATELET THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART PALPITATION; HEPATITIS; HUMAN; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; MULTIVESSEL CORONARY ARTERY DISEASE; NEUTROPENIA; OPEN STUDY; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIPLE ANTIPLATELET THERAPY; UNSPECIFIED SIDE EFFECT;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; SIROLIMUS; TETRAZOLES; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892792224     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.08.028     Document Type: Article

References (16)

1. S. Bangalore, S. Kumar, and M. Fusaro et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
2. H.K. Win, A.E. Caldera, and K. Maresh et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents JAMA 297 2007 2001 2009
3. S.W. Lee, S.W. Park, and Y.H. Kim et al. Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial) Am J Cardiol 100 2007 1103 1108
4. S.W. Lee, S.W. Park, and Y.H. Kim et al. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients) J Am Coll Cardiol 51 2008 1181 1187
5. S.W. Lee, S.W. Park, and Y.H. Kim et al. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial J Am Coll Cardiol 57 2011 1264 1270
6. J.W. Suh, S.P. Lee, and K.W. Park et al. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial J Am Coll Cardiol 57 2011 280 289
7. S. Windecker, P.W. Serruys, and S. Wandel et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Lancet 372 2008 1163 1173
8. R. Moreno, C. Fernandez, and A. Sanchez-Recalde et al. Clinical impact of in-stent late loss after drug-eluting coronary stent implantation Eur Heart J 28 2007 1583 1591
9. Y. Takamiya, S. Miura, and A. Kawamura et al. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease Coron Artery Dis 20 2009 288 294
10. A.J. Carter, J.R. Laird, and A. Farb et al. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model J Am Coll Cardiol 24 1994 1398 1405
11. R.S. Schwartz, N.A. Chronos, and R. Virmani Preclinical restenosis models and drug-eluting stents: still important, still much to learn J Am Coll Cardiol 44 2004 1373 1385
12. Y.H. Jeong, S.W. Lee, and B.R. Choi et al. Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study J Am Coll Cardiol 53 2009 1101 1109
13. J. Daemen, P. Wenaweser, and K. Tsuchida et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
14. D.S. Pinto, G.W. Stone, and S.G. Ellis et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial J Am Coll Cardiol 48 2006 32 36
15. J.M. ten Berg, J.C. Kelder, and M.J. Suttorp et al. Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study J Am Coll Cardiol 38 2001 1061 1069
16. T. Uchida, J. Popma, and G.W. Stone et al. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions JACC Cardiovasc Interv 3 2010 403 411